Table 4.
Outcomes of patients
| Variables |
All patients N = 438 |
Peripheral PE N = 305 |
Central PE N = 133 |
P value |
|---|---|---|---|---|
| All-cause hospital mortality, N (%) | 27 (6.2) | 20 (6.6) | 7 (5.3) | 0.61 |
| Pulmonary embolism-related hospital mortality, N (%) | 16 (3.7) | 10 (3.3) | 6 (4.5) | 0.58 |
| Six-moth mortality, N (%) | 69/379 (18.2) | 51/269 (19.0) | 18/110 (16.4) | 0.55 |
| Unable to assess six-month mortality due to follow-up loss (% of study patients) | 59/438 (13.5) | 36/305 (11.8) | 23/133 (17.3) | 0.13 |
| Bleeding in a critical area or organ, N (%) | 27 (6.2) | 19 (6.2) | 8 (6.0) | 0.93 |
| Intracranial bleeding, N (%) | 7 (1.6) | 5 (1.6) | 2 (1.5) | 0.92 |
| Bleeding leading to blood transfusion, N (%) | 19 (4.3) | 13 (4.3) | 6 (4.5) | 0.91 |
| Fatal bleeding, N (%) | 8 (1.8) | 5 (1.6) | 3 (2.3) | 0.66 |
| ICU LOS (days) for patients who needed ICU admission, median (Q1, Q3) | 4.0 (2.0, 10.5) | 3.0 (7.0, 12.0) | 3.0 (2.0, 6.5) | 0.01** |
| Hospital LOS (days), median (Q1, Q3) | 6.0 (3.0, 11.0) | 5.0 (3.0, 11.0) | 7.0 (4.0, 11.0) | 0.03** |
ICU Intensive care unit, LOS Length of stay, MV Mechanical ventilation, Q1 First quartile, Q3 Third quartile, RRT Renal replacement therapy, VTE Venous thromboembolism
*Student t test
** Mann–Whitney U test